Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in TNXP — Tonix Pharmaceuticals Holding Corp.

CIK 1595888 NEW YORK, NY
Back to TNXP Full portfolio

Position in TNXP

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
16 quarters on record

Common Shares in TNXP Over Time

Shares Held

Position Value (USD)

Derivatives in TNXP

reported options exposure · as of Jun 30, 2026
CallValue
$514,228
CallShares
40,300
PutValue
$1,778,744
PutShares
139,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,372,940,661 across 293 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 2,934,193 $218,538,693
2 MDGL
Madrigal Pharmaceuticals, Inc.
 191,541 $102,847,939
3 AXSM
Axsome Therapeutics, Inc.
 403,995 $98,885,855
4 TGTX
Tg Therapeutics, Inc.
 1,752,646 $96,290,370
5 EXEL
Exelixis, Inc.
 1,402,438 $76,306,651
6 QURE
uniQure N.V.
 1,610,483 $74,178,846
7 HALO
Halozyme Therapeutics, Inc.
 694,684 $54,372,915
8 TVTX
Travere Therapeutics, Inc.
 938,699 $53,327,489

All Filings in TNXP

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,778,744 139,400
2026-06-30 $514,228 40,300
2026-03-31 $1,038,125 75,500
2026-03-31 $335,500 24,400
2025-12-31 $404,558 25,900
2025-12-31 $235,862 15,100
2025-12-31 $478,377 30,626
2025-09-30 $294,752 12,200
2024-12-31 $548,684 1,662,682
2024-09-30 $4,134 27,563
2024-06-30 $7,664 10,950
2024-03-31 $2,608 13,728
2022-12-31 $5,943 15,240
2022-09-30 $13,242 24,985
2022-06-30 $16,684 10,560
2022-03-31 $30,276 131,636
2021-12-31 $111,353 309,315
2021-09-30 $47,454 79,091
2021-06-30 $13,323 12,003
2020-06-30 $37,824 62,008